NTRS vs BBIO

Comparison between Northern Trust Corp (NTRS, Company) and BridgeBio Pharma Inc (BBIO, Company).

NTRS is from the Financial Services sector, while BBIO is from the Healthcare sector.

5-Year PerformanceNTRS has outperformed BBIO, delivering a return of +13.8% compared to +9.2%

NTRS vs BBIO - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	NTRS(COMPANY)	BBIO(COMPANY)
Market Cap	$16B	$16B
Max Drawdown	68.66%	92.80%
Sharpe Ratio	1.54	1.30
5Y Beta	1.02	1.02
Industry	Asset Management	Biotechnology
P/E Ratio	8.92	-22.15
Forward P/E	16.89	N/A
PEG Ratio	1.20	-3.95
Dividend Yield	1.76%	N/A
5Y Dividends CAGR	7.12%	N/A
5Y EPS CAGR	11.13%	-3.14%
Debt to Equity	0.00%	-116.44%
Free Cash Flow Yield	14.56%	-2.72%
P/S Ratio	2.40	28.21
P/B Ratio	1.78	123.68

Market Cap

Winner

NTRS

$16B

BBIO

$16B

Max Drawdown

Winner

NTRS

68.66%

BBIO

92.80%

Sharpe Ratio

Winner

NTRS

1.54

BBIO

1.30

5Y Beta

Winner

NTRS

1.02

BBIO

1.02

Industry

NTRS

Asset Management

BBIO

Biotechnology

P/E Ratio

NTRS

8.92

Winner

BBIO

-22.15

Forward P/E

NTRS

16.89

BBIO

N/A

PEG Ratio

NTRS

1.20

Winner

BBIO

-3.95

Dividend Yield

NTRS

1.76%

BBIO

N/A

5Y Dividends CAGR

NTRS

7.12%

BBIO

N/A

5Y EPS CAGR

Winner

NTRS

11.13%

BBIO

-3.14%

Debt to Equity

NTRS

0.00%

Winner

BBIO

-116.44%

Free Cash Flow Yield

Winner

NTRS

14.56%

BBIO

-2.72%

P/S Ratio

Winner

NTRS

2.40

BBIO

28.21

P/B Ratio

Winner

NTRS

1.78

BBIO

123.68

NTRS vs BBIO - Historical Returns

Returns include dividend reinvestment.

Period	NTRS	BBIO
1 month	+3.35%	+6.32%
3 months	+13.66%	+18.96%
6 months	+22.23%	+9.15%
1 year	+46.18%	+71.87%
5 years(CAGR)	+13.77%	+9.21%
10 years(CAGR)	+13.63%	N/A
Max(CAGR)	+7.36%	+16.61%

NTRS

+3.35%

Winner

BBIO

+6.32%

NTRS

+13.66%

Winner

BBIO

+18.96%

Winner

NTRS

+22.23%

BBIO

+9.15%

NTRS

+46.18%

Winner

BBIO

+71.87%

5Y(CAGR)

Winner

NTRS

+13.77%

BBIO

+9.21%

10Y(CAGR)

NTRS

+13.63%

BBIO

N/A

Max(CAGR)

NTRS

+7.36%

Winner

BBIO

+16.61%

NTRS vs BBIO - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

Year	NTRS	BBIO
2026	+32.34%	+4.90%
2025	+36.23%	+171.24%
2024	+24.92%	-32.16%
2023	-2.39%	+463.04%
2022	-24.51%	-55.59%
2021	+32.55%	-73.79%
2020	-10.25%	+114.06%
2019	+29.86%	+27.22%
2018	-14.31%	N/A
2017	+13.41%	N/A
2016	+28.77%	N/A
2015	+8.83%	N/A
2014	+12.92%	N/A
2013	+22.10%	N/A
2012	+26.63%	N/A
2011	-27.24%	N/A
2010	+7.82%	N/A
2009	+0.61%	N/A
2008	-28.41%	N/A
2007	+26.89%	N/A
2006	+18.00%	N/A
2005	+11.22%	N/A
2004	+7.00%	N/A
2003	+29.21%	N/A
2002	-40.27%	N/A
2001	-24.00%	N/A
2000	+62.85%	N/A
1999	+9.29%	N/A

NTRS vs BBIO Drawdown Comparison

The maximum drawdown for NTRS was -67.67%, occurring on Mar 11, 2003. Recovery took 1913 trading sessions.

The maximum drawdown for BBIO was -92.80%, occurring on May 11, 2022. Recovery took 1211 trading sessions.

The current NTRS drawdown is -4.56%. The current BBIO drawdown is -8.98%.

Rank	NTRS	BBIO
#1	-67.67% Dec 7, 2000 - Jul 22, 2008	-92.80% Feb 8, 2021 - Dec 3, 2025
#2	-60.45% Sep 11, 2008 - May 18, 2015	-65.45% Dec 23, 2019 - Nov 24, 2020
#3	-50.00% Jan 14, 2022 - Jun 23, 2025	-44.53% Sep 3, 2019 - Nov 20, 2019
#4	-42.75% Dec 12, 2019 - Mar 26, 2021	-21.99% Dec 31, 2020 - Feb 8, 2021
#5	-30.01% Jul 16, 2015 - Nov 9, 2016	-20.25% Jan 22, 2026 - Jul 9, 2026
#6	-29.98% Jul 24, 2018 - Dec 6, 2019	-16.79% Nov 22, 2019 - Dec 9, 2019
#7	-21.14% Mar 22, 2000 - Jul 14, 2000	-14.67% Jul 22, 2019 - Aug 26, 2019
#8	-18.83% Sep 12, 2000 - Dec 7, 2000	-12.87% Jul 11, 2019 - Jul 22, 2019
#9	-13.51% Feb 1, 2000 - Mar 16, 2000	-11.32% Jul 9, 2026 - Aug 3, 2026
#10	-13.12% Aug 27, 2021 - Oct 15, 2021	-6.70% Dec 12, 2019 - Dec 18, 2019
#11	-12.37% Feb 9, 2026 - Apr 13, 2026	-6.15% Jan 2, 2026 - Jan 13, 2026
#12	-12.34% Dec 30, 1999 - Jan 13, 2000	-5.62% Jul 5, 2019 - Jul 11, 2019
#13	-12.18% Jul 5, 2017 - Dec 4, 2017	-5.28% Aug 27, 2019 - Sep 3, 2019
#14	-10.61% Jun 1, 2021 - Aug 27, 2021	-4.46% Dec 1, 2020 - Dec 4, 2020
#15	-10.45% Jan 22, 2018 - Feb 26, 2018	-4.45% Dec 18, 2019 - Dec 20, 2019